Liquid biopsy and health-related quality of life in cancers: a systematic review
{{output}}
Liquid biopsy, using circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs), is gaining ground as a noninvasive strategy in cancer care. Beyond its diagnostic and monitoring roles, its potential to impact health-related quality of life (HRQoL) is inc... ...
